Analysis of fatigue in non-small cell lung cancer patients treated with second-line pemetrexed

被引：0
|
作者：
Li, Li [1 ]
Winfree, Katherine B. [1 ]
Pennella, Eduardo J. [1 ]
Girvan, Allicia C. [1 ]
Pohl, Gerhardt [1 ]
Obasaju, Coleman K. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20629
引用
收藏
页数：2
相关论文
共 50 条
  • [1] An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer
    Scagliotti, G
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2855 - 2866
  • [2] Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin
    Tiseo, Marcello
    Giovannetti, Elisa
    Tibaldi, Carmelo
    Camerini, Andrea
    Di Costanzo, Francesco
    Barbieri, Fausto
    Burgers, Jacobus A.
    Vincent, Andrew
    Peters, Godefridus J.
    Smith, Egbert F.
    Ardizzoni, Andrea
    [J]. LUNG CANCER, 2012, 78 (01) : 92 - 99
  • [3] The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Tucker, Steven
    [J]. CURRENT DRUG TARGETS, 2010, 11 (01) : 58 - 60
  • [4] Pemetrexed in second line of non-small cell lung cancer
    Earata, Fernando
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2008, 14 : S21 - S26
  • [5] Pemetrexed vs docetaxel cost analysis in second-line non-small cell lung cancer treatment
    Ravasio, Roberto
    [J]. FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2005, 6 (02) : 119 - 126
  • [6] Second-line chemotherapy for non-small cell lung cancer
    De Marinis, F.
    De Santis, S.
    De Petris, L.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V68 - V71
  • [7] Non-small cell lung cancer: second-line and beyond
    Stahel, R. A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : X97 - X100
  • [8] Second-line chemotherapy for non-small cell lung cancer
    Ruckdeschel, JC
    [J]. CHEST, 2006, 129 (04) : 840 - 842
  • [9] Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer
    Schiller, Joan H.
    von Pawel, Joachim
    Schuett, Philipp
    Ansari, Rafat H.
    Thomas, Michael
    Saleh, Mansoor
    McCroskey, Robert D.
    Pfeifer, Wolfgang
    Marsland, Thomas A.
    Kloecker, Goetz H.
    Sebastian, Martin
    Pirker, Robert
    Kurek, Raffael
    Beadman, Claire
    Socinski, Mark A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : 1977 - 1985
  • [10] Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer
    Zhang Yi-fei
    Chen Zhi-wei
    Lu Shun
    [J]. CHINESE MEDICAL JOURNAL, 2009, 122 (20) : 2472 - 2476
12345